Detection of Antigen-Specific T Cells with Multivalent Soluble Class II MHC Covalent Peptide Complexes  by Crawford, Frances et al.
Immunity, Vol. 8, 675±682, June, 1998, Copyright 1998 by Cell Press
Detection of Antigen-Specific T Cells
with Multivalent Soluble Class II MHC
Covalent Peptide Complexes
Recently, methods for producing soluble MHC mole-
cules and abTCRs have been developed (Matsui et al.,
1991; Matsumura et al., 1992; Stern and Wiley, 1992;
Corr et al., 1994; Kappler et al., 1994; Kozono et al.,
1994; Matsui et al., 1994; Garboczi et al., 1996; Garcia
Frances Crawford,* Haruo Kozono,*‖
Janice White,* Philippa Marrack,²³
and John Kappler²§
*Howard Hughes Medical Institute
Division of Basic Immunology
et al., 1996), allowing the measurement of the affinityNational Jewish Medical and Research Center
of abTCRs for MHC molecules loaded with particularDenver, Colorado 80206
peptides. These experiments have shown that these²Departments of Immunology and Medicine
interactions are of very low affinity, with dissociation³Department of Biochemistry, Biophysics,
constants usually no better than 1±100 mM (Corr et al.,and Genetics
1994; Matsui et al., 1994; Alam et al., 1996; Fremont etUniversity of Colorado Health Science Center
al., 1996; Garcia et al., 1997; Khandekar et al., 1997;Denver, Colorado 80262
Seibel et al., 1997; Liu et al., 1998), too weak for these
peptide-loaded MHC molecules to be useful directly in
detecting peptide-specific T cells. However, recently
Summary several studies (Altman et al., 1996; McHeyzer-Williams
et al., 1996; Murali-Krishna et al., 1998) have shown that
Multimeric soluble MHC class II molecules stably oc- when soluble MHC/peptide complexes are multimer-
cupied with covalently attached peptides bind with ized, they achieve much higher avidities for the abTCR
appropriate specificity to T cell hybridomas and T cells on the T cell surface, presumably via cooperative multi-
from T cell receptor transgenic mice. There is a direct valent binding.
correlation between soluble T cell receptor affinity for In the current study, we combined the use of soluble
monomeric MHC/peptide and level of binding of multi- multivalent MHC class II molecules with a method that
meric MHC/peptide to T cells. While binding of the assures complete stable occupancy of the MHC binding
multimeric MHC/peptide complex is proportional to T groove with a single peptide by genetically attaching
cell receptor affinity and expression level, there is little the peptide to the MHC molecule with a flexible linker.
influence of T cell CD4. We prepared a variety of these reagents and show that
they bind specifically to normal T cells and T cell hybrid-
omas. We also show that the level of binding is propor-
Introduction tional to the affinity of the abTCR for monomeric MHC/
peptide.
The ability of antibody to bind directly to antigen has
been a useful tool in following the fate and migration Results
pathway of antigen-specific B cells during the course
of an immune response (Biozzi et al., 1967; Sercarz and Specific Binding of Multivalent MHC/Peptide
Modabber, 1968; Greenstein et al., 1980) or establish- to T Cell Hybridomas
ment of self-tolerance (Goodnow et al., 1990). Antigen± As described in the Experimental Procedures, soluble
antibody interactions have also been used to document IEk bearing a covalently attached moth cytochrome c
the maturation of antibody affinity through primary and (MCC) or mouse hemoglobin (Hb) peptide was prepared
secondary immune responses (Berek and Milstein, 1987). with a biotinylated peptide tag on the b chain C terminus
Such experiments have been much harder with T cells (bio-IEkMCC and bio-IEkHb). Purified multivalent com-
since the ligand for the T cell a/b antigen receptor plexes of these MHC molecules with phycoerythrin/
(abTCR) is not a free antigen but the combination of an streptavidin (PESA) were prepared. Various concentra-
antigenic peptide fragment bound to a self-MHC mole- tions of the bio-IEkMCC-PESA complex were incubated
cule. As a substitute, a number of investigators have with a T cell hybridoma, KMAC-92, specific for IEk/MCC,
used monoclonal antibodies (MAbs) specific for the a/b for 2 hr at 378C in complete tissue culture medium con-
combination of a particular abTCR. Such anti-idiotypic taining 10% FCS and 5 mM NaN3. As a negative control,
reagents have been extremely useful in tracking particu- the hybridoma cells were incubated identically with the
lar T cells in vivo, especially when combined with mice bio-IEkHb-PESA complex. The cells were then washed
bearing a transgenic abTCR reactive with the MAb (Teh and the bound bio-IEkpeptide-PESA complexes ana-
et al., 1989; Pape et al., 1997). However, this approach lyzed by flow cytometry. The results are shown in Fig-
has required the sometimes difficult preparation of an ures 1A and 1B. Virtually no binding of the control Hb-
individual anti-idiotypic MAb for each T cell clone to be containing complex was seen at any dose (Figure 1A),
studied and has not been useful in studying the normal but the specific MCC-containing complex bound strongly
heterogeneous T cell response to a particular MHC/ in a dose-dependent manner (Figure 1B). Saturation
peptide combination. binding was not seen even at 32 mg/ml of the complex;
however, to conserve reagent most subsequent experi-
ments were performed at 20 mg/ml.§To whom correspondence should be addressed (e-mail: kapplerj@
The time course of binding of the bio-IEkMCC-PESAnjc.org).
complex was assessed, again using the Hb peptide-‖ Present address: Research Institute for Biological Sciences, Sci-
ence University of Tokyo, 2669 Yamazaki, Noda, Chiba 278, Japan. containing complex as the negative control. Cells were
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Two additional versions of the bio-MHC class II pep-
tide±PESA complexes were prepared as described in
the Experimental Procedures. The first contained IEk
with a variant of the MCC peptide in which amino acid
99 was changed from lysine to alanine (IEkMCC99A).
The other contained IAd with a peptide corresponding
to amino acids 328±338 of chicken ovalbumin (IAdOVA).
The four multimeric reagents were used to stain a series
of T cell hybridomas of various specificities. In each
case, the hybridoma was incubated with a complex con-
taining the appropriate MHC/peptide combination and,
as a negative control, with a complex containing an
inappropriate MHC/peptide combination. In addition,
the hybridomas were incubated with an anti-Cb mono-
clonal antibody to measure total surface abTCR. The
results are shown in Figure 2. Complexes containing the
appropriate MHC/peptide combination bound to eachFigure 1. Specific Binding of Multivalent IEkMCC to a T Cell Hy-
bridoma T cell hybridoma, although the extent of binding varied
over more than a 100-fold range. Poor to no binding wasKMAC-92 hybridoma cells (1 3 105) were incubated with various
concentrations of (A) bio-IEkHb±PESA or (B) bio-IEkMCC±PESA in a seen with the inappropriate combination, demonstrating
volume of 50 ml of complete tissue culture medium containing 5 the highly specific nature of the reagents.
mM NaN3 for 2 hr at 378C. The cells were washed 33 with PBS
containing 2% FCS and 5 mM NaN3 and analyzed for bound PE
Factors Influencing the Binding of Multivalentfluorescence. Under similar conditions, KMAC-92 cells were incu-
MHC/Peptide to T Cell Hybridomasbated with 20 ug/ml (C) bio-IEkHb±PESA or (D) bio-IEkMCC±PESA
for various times before washing and flow cytometric analysis. We performed a series of experiments to evaluate fac-
tors influencing the wide range of binding shown in Fig-
ure 2. We postulated that at least three factors could
play a role in the amount of binding of the multivalentincubated with the reagents for various times at 378C
in complete tissue culture medium containing 10% FCS complexes: (1) the level of abTCR expression; (2) the
affinities of the abTCRs for the MHC/peptide ligand;and 5 mM NaN3 before they were washed and analyzed.
The results are shown in Figures 1C and 1D. Again, no and (3) the relative involvement of CD4/class II MHC
interactions in stabilizing the binding.significant binding of the Hb-containing complex was
seen at any time tested (Figure 1C). Strong binding of To test the relation between abTCR levels and the
level of binding, we prepared a series of subclones fromthe MCC complex was seen within 20 min (Figure 1D).
Roughly twice as much was bound by 1 hr and three the T cell hybridoma KMAC-92 with surface abTCR lev-
els that varied over a factor of three. The binding of bio-times as much by 3 hr. In subsequent experiments, incu-
bations with the complexes were for 2±3 hr. IEkMCC±PESA to the clones was compared to that of
Figure 2. Summaryof BindingStudies ofMulti-
valent MHC/Peptide to T Cell Hybridomas
In each of the 12 panels, 1 3 105 hybridoma T
cells of known MHC/peptide specificity were
incubated for 2 to 3 hr with 20 mg/ml of PESA
complexed with the appropriate bio-MHC/
peptide. The cells were washed and analyzed
for bound PESA (unevenly dashed line) as in
Figure 1. Except for hybridoma KH-2 in panel
D, aliquots of the cells were labeled also with
the anti-mouse Cb antibody, H597 (dotted
line). As a negative control, cells were pre-
pared identically with complexes containing
an inappropriate peptide and/or MHC mole-
cule (solid line). This negative reagent was
bio-IEkHb±PESA in panels A, B, C, H±L, and
bio-IEkMCC±PESA in panels D±G. Finally, in
panel L, in addition to the bio-IEkMCC99A±
PESA, the KHAMA-93 hybridoma cells were
incubated with bio-IEkMCC±PESA (dashed
line).
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Figure 4. Lack of Influence of CD4 on Binding of Multivalent MHC/
Peptide
(A) A CD41 (closed circles) and CD42 (open circles) clone of the
hybridoma B10.D2±22 were tested for response to various concen-
Figure 3. Correlation between Level of Surface abTCR and Binding trations of OVA327±339 peptide presented by the IAd-bearing
of Multivalent MHC/Peptide to T Cell Hybridomas BALB/c lymphoma A20. The data are presented as units of IL-2
The hybridoma KMAC-92 was cloned at limiting dilution and 20 produced versus peptide concentration.
clones were assessed for binding of either bio-IEkMCC±PESA or an (B and C) The CD41 (closed bars) and CD42 (open bars) clones of
anti-Cb MAb as in Figures 1 and 2. B10.D2-22 were incubated with bio anti-Cb 1 PESA, fluorescein
anti-CD4, bio-IEkMCC±PESA, or bio-IAdOVA±PESA. The data are
presented as the mean fluorescence of the labeled population cor-an anti-Cb monoclonal antibody. The results are shown
rected for the fluorescence seen with nothing (CD4) or PESA alone
in Figure 3. Over this range of expression, there was a (others).
linear correlation between the level of abTCR expression
determined with the anti-Cb reagent and the binding of
the MHC/peptide complex.
in Figure 2 for their MHC/peptide ligands (Seibel et al.,Next, we examined the possible role of CD4 in the
1997; Liu et al., 1998). To complement these measure-binding of these reagents to the T cell hybridomas. CD4
ments, we prepared soluble abTCR from an additionalcan enhance signaling through the abTCR by binding
T cell hybridoma, KHAMA-93, as described in theExperi-to MHC class II and recruiting p56lck to the signaling
mental Procedures. This hybridoma bound its multi-complex (Veillette et al., 1988). It has been suggested
valent-specific ligand, IEkMCC99A, as well as any hy-that by interaction with both MHC class II and the
bridoma we have tested and showed very weak butabTCR, CD4 can also enhance signaling via stabilization
detectable cross-reactive binding to the related multiva-of the abTCR/MHC complex (Doyle and Strominger,
lent ligand containing IEkMCC (Figure 2L). As described1987; Gay et al., 1988; Portoles and Janeway, 1989). It
in the Experimental Procedures, we used the BIAcorewas possible that the geometry of the multivalent class
system to measure the affinities of this receptor forII could still allow for this interaction, increasing the
monovalent versions of these MHC/peptide ligands. Thestability of the complex bound to the T cell surface. To
soluble abTCR was immobilized in the flow cells of atest this idea, we examined CD41 and CD42 subclones
biosensor chip. Various concentrations of monovalentof a T cell hybridoma, 2B10.D2-22, specific for IAd/OVA.
IEk bearing either peptide were injected and the bindingWe established that the IL-2 response of this T cell
kinetics followed.hybridoma to an OVA peptide presented by an IAd-bear-
Figure 5Ashows the data for IEkMCC99A. This reagenting B cell line was dependent on CD4. The results are
bound the KHAMA-93 abTCR extremely well. The ka wasshown in Figure 4A. The CD42 subclone of the hybrid-
calculated as 36000 M21s21 and the kd as 0.176 s21 foroma required about a 10-fold greater concentration of
a calculated overall KD of 4.9 mM and a complex half-the OVA peptide and produced a lower plateau response
life of about 8 seconds. This is among the highest affinitythan the CD41 subclone, despite the fact that both had
abTCRs described for MHC class II/peptide ligands.an equivalent level of surface abTCR (Figures 4B and
The maximum binding values in Figure 5A were used to4C). We also compared the binding of bio-IAdOVA±PESA
construct a Scatchard plot (Figure 5C). The KD of theto each of the hybridoma subclones (Figures 4B and
interaction calculated from this equilibrium data was 44C). The reagent bound equally well to both subclones,
mM, in good agreement with the kinetic data. Thealthough no significant binding of a negative reagent,
KHAMA abTCR bound the IEkMCC ligand very poorlybio-IEkMCC±PESA, was seen. These results suggest
(Figure 5B), in agreement with the binding data in Figurethat, at least under these conditions, CD4 does not con-
2L. Barely detectable binding was seen only at very hightribute significantly in stabilizing the binding of these
MHC concentrations (15±60 mM). This binding was toomultivalent MHC/peptide reagents to the T cell surface.
weak to calculate a KD directly from the binding kinetics;Finally, we examined the relation between receptor
however, the maximal binding could be used to estimateaffinity and level of binding of the multimeric MHC/pep-
a minimal KD from the Scatchard plot in Figure 5C. If onetide. We have previously used surface plasmon reso-
assumes the same number of potential abTCR bindingnance to measure the affinities of soluble abTCRs pre-
pared from a number of the T cell hybridomas shown sites in the flow cell for IEkMCC as for IEkMCC99A, one
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the relation between soluble abTCR affinities for mono-
valent MHC/peptide and the binding of multivalent
MHC/peptides for all of the T cell hybridomas for which
we have been able to make both measurements. In this
figure, the MHC/peptide binding has been normalized
to the level of abTCR surface expression on each hybrid-
oma, and the affinities are reported as KAs rather than
KDs. There is a striking linear relationship between the
abTCR affinities and the binding of the multimeric MHC/
peptide to the T cell hybridoma over a 100- to 1000-fold
range.
Binding to Normal and abTCR Transgenic T Cells
These experiments established the ability of these
Figure 5. Affinities of the KHAMA abTCR for Monomeric MHC Class multimeric class II MHC/peptide complexes to bind spe-
II/Peptide cifically to the abTCR on T cell hybridomas. As a final
The binding kinetics of various concentrations of monomeric (A) experiment, we wished to establish that these reagents
IEkMCC99A or (B) IEkMCC to immobilized KHAMA-93 are shown.
were capable of detecting the abTCR on normal T cells.The class II molecules were injected at a flow rate of 10 ul/min for
Therefore, we examined their binding to T cells taken1 min, and the binding curves have been corrected for bulk fluid
phase signal. The IEkMCC99A binding kinetics were analyzed with from mice transgenic for Va11/Vb3 abTCRs specific for
standard BIAcore software, and the average calculated ka, kd, half- IEk/MCC. Two types of mice were used. One carried the
life of the complex and KD are shown. (C) The maximal binding data AD10 and the other the AND abTCR (Kaye et al., 1992).
in panel A were used to construct a Scatchard plot for IEkMCC99A As a control, T cells from normal IEk-bearing B10.BR
binding to the immobilized KHAMA-93 abTCR. A least squares re-
mice were used. We examined these T cells for bindinggression line was fit to the data and the KD of the interaction esti-
of bio-IEkMCC±PESA, bio-IEkMCC99A±PESA, and as amated from the negative reciprocal of the slope of the fitted line.
The intersection of this line with the x-axis estimated the maximal control, binding of an anti-Vb3 monoclonal antibody.
binding capacity of the flow cells as 760 RU. By assuming the same The results are shown in Figure 7.
potential binding capacity for the poorly binding IEk-MCC ligand, Virtually no binding of either MHC reagent was seen
the KD of this interaction was approximated. to normal B10.BR CD41 T cells, an expected finding
since the frequency of T cells reactive to these peptides
can estimate that the KD of the IEkMCC for the abTCR should be very low in unimmunized mice (Figure 7A). On
is about 700 mM. the other hand, bio-IEkMCC±PESA bound very strongly
These results suggest a direct correlation between to the majority of CD41 T cells from the transgenic mice
receptor affinity and the binding of the multivalent MHC/ (Figures 7B and 7C). Binding of bio-IEkMCC99A±PESA
peptide complex to the T cell hybridoma. This point is was undetectable to CD41 T cells from the mice carrying
made even more dramatically in Figure 6, which shows the AD10 abTCR and severely reduced compared to the
MCC containing reagent with CD41 T cells from mice
bearing the AND abTCR. This was expected, since the
lysine at position 99 of the MCC peptide has been shown
to be critical for T cell recognition.
The level of Vb3 on the surface of CD41 T cells from
all three mice was similar (Figure 7D), indicating that
the binding of the bio-IEkMCC±PESA did not require an
unusually high surface level of abTCR. Virtually all CD41
T cells from both transgenic mice expressed high levels
of the transgenic Vb3-bearing b chain. However, only
70% of the AD10 T cells bound bio-IEkMCC±PESA
strongly (Figure 7D). Most of the remaining cells bound
the reagent poorly, but significantly better than did the
normal B10.BR control T cells. This most likely reflected
the expression of a second a chain in these cells that
Figure 6. Correlation of Binding of Multivalent MHC/Peptide to T variably suppressed, but did not eliminate, the expres-
Cell Hybridomas with abTCR Affinities sion of the transgenic a chain.
The binding of bio-MHC/peptide±PESA to T cell hybridomas aver-
aged from several experiments and presented as the ratio of binding
Discussionof the MHC reagents to binding with an anti-Cb MAb are plotted
versus the average affinity (KA, liters/mole) of the corresponding
soluble abTCR for monovalent MHC-peptide. The MHC/abTCR Recent experiments with soluble abTCRs and MHC mol-
combinations were: (closed circle) IEkMCC99A, KHAMA-93; (square) ecules have revealed much about the nature of their
IEkMCC, 5KC-73; (closed triangle) IEkMCC, KMAC-92; (closed dia- interaction. Experiments with surface plasmon reso-
mond) IEkMCC, KMAC-126; (upside down closed triangle) Pooled
nance have shown that abTCRs have low affinities fordata for IAdOVA with DO-11.10 and 2B10. D2±22, since these hybrid-
their activating MHC/peptide ligands, with KDs typicallyomas have identical receptors (Seibel et al., 1997); and (multiplica-
tion sign) IEkMCC, KHAMA-93. in the range of 1±100 mM (Corr et al., 1994; Matsui et
Binding of Multivalent MHC Class II to T Cells
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In this paper, we show that the combination of a cova-
lently attached peptide and multimerization via a biotin-
ylated C-terminal tag produces a reagent that binds to T
cells and T cell hybridomas with appropriate specificity.
In addition to improving peptide homogeneity, the
peptide linker should improve the long-term stability of
these reagents. Although dissociation of peptides from
class II is generally very slow, it is significant over the
course of many days, while we have found peptide occu-
pancy with covalently bound peptides is stable over
many months. One potential problem with this covalent
construction is that occasionally the linker attached to
the peptide C terminus may get in the way of abTCR
binding. In the one case where we have seen this inter-
ference, recognition was restored by proteolytic cleav-
age of the linker after assembly (data not shown). This
cleavage is most easily accomplished by including a
thrombin recognitionsequence within the linker (Kozono
et al., 1994).
These types of reagents have obvious usefulness in
identifying and tracking antigen-specific T cells duringFigure 7. Detection of Normal T Cells Bearing a Transgenic abTCR
normal or pathogenic immune responses. In addition,Nylon fiber nonadherent T cells were purified from lymph nodes of
normal (A) B10.BR mice or B10.BR mice expressing either the (B) our results show that the level of binding of multimeric
AD10 or (C) AND transgenic Va11/Vb3-bearing abTCR. Separate MHC class II/peptide complexes to T cells is directly
aliquots of the cells were incubated with fluorescein-labeled anti- proportional to the affinity of the abTCR for the MHC
CD4 and either bio-IEkMCC±PESA (straight line) or bio-IEkMCC99A± class II/peptide complex. The need to know abTCR af-
PESA (dotted line). Histograms show the PE fluorescence of the
finities has become important inunderstanding the func-CD41 cells. (D) Aliquots of the three types of T cells were incubated
tion of T cells. For example, differences in the affinitieswith fluorescein-labeled anti-CD4 and biotinylated anti-Vb3 (de-
of abTCRs for positively selecting versus deleting ortected with PESA). The histograms show the PE fluorescence of the
CD41 cells. activating MHC ligands has been hypothesized to ac-
count for the repertoire of T cells that make up the
mature peripheral repertoire (Ashton-Rickardt and To-al., 1994; Alam et al., 1996; Fremont et al., 1996; Garcia
negawa, 1994; Hogquist et al., 1994; Sebzda et al., 1994;et al., 1997; Khandekar et al., 1997; Seibel et al., 1997;
Alam et al., 1996; Lyons et al., 1996; Liu et al., 1998). In
Liu et al., 1998). MHC/peptide ligands involved in T cell
the periphery, the relative affinity of T cells for an MHC
positive and negative selection can have even lower
ligand may play a part in the decision between produc-
affinities (Ashton-Rickardt and Tonegawa, 1994; Sebzda
tive activation versus anergy or deletion (Matsui et al.,
et al., 1994; Alam et al., 1996; Lyons et al., 1996; Liu 1994; Alam et al., 1996; Lyons et al., 1996). Thus, abTCR
et al., 1998). These affinities are too low to use mono- affinity may play a role in the escape of autoimmune T
meric soluble MHC molecules as reagents for detecting cells from negative selection. Methods measuring the
antigen-specific T cells. Recently, however, multimeric affinities of abTCRs for their MHC/peptide ligands have
class I or class II MHC molecules have been shown to improved considerably in recent years; however, they
have increased avidity for T cells bearing the abTCRs require the sometimes difficult task of producing high
of appropriate specificity (Altman et al., 1996; McHeyzer- quantities of native soluble abTCRs. In addition, mea-
Williams et al., 1996; Murali-Krishna et al., 1998), pre- surements of affinities in the range of KAs between 103
sumably because of the cooperative effect of multipoint and 104 M21 are extremely costly and difficult. Our results
binding. suggest that abTCR affinities can be estimated in the
A critical requirement of such reagents is the complete range of about 103 to 106 M21 with these multimeric
occupancy of the MHC molecule with a single peptide, reagents, making them very useful in addressing some
since heterogeneity in the multimer reduces the poten- of these questions.
tial for multipoint binding. MHC molecules that are With the protocols we used here, we were unable to
empty or poorly loaded have been prepared in various detect any contribution of CD4 to the overall level of
binding with these reagents. Since the ability of CD4 toexpression systems and subsequently loaded uniformly
interact with class II MHC is well documented (Doylein vitro with a single peptide (Matsui et al., 1991; Matsu-
and Strominger, 1987; Gay et al., 1988), either the geom-mura et al., 1992; Stern and Wiley, 1992; Altman et al.,
etry of these reagents precludes incorporation of CD41993; Kozono etal., 1994). Becausethe stability of empty
or the interaction is of such low affinity that it does notMHC molecules is isotype and allele specific, the effi-
contribute significantly to the overall binding avidity atciency of this in vitro peptide loading approach is quite
this valency.variable. We have largely solved this problem for MHC
class II by genetically coupling the peptide of interest
Experimental Proceduresto the N terminus of the b chain via a flexible linker,
so that the peptide is covalently attached to the MHC Soluble MHC Class II Molecules with Covalent Peptides
molecule and stably occupies the peptide binding Soluble MHC class II molecules were prepared using baculovirus
as previously described (Kozono et al., 1994, 1995). The IEk moleculegroove during biosynthesis (Kozono et al., 1994, 1995).
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was produced in combination with three different peptides: a pep- previous publications. Their specificities and names are as follows:
IEk/MCC-specific, 5KC-73 (White et al., 1993), KMAC-92 (Liu et al.,tide corresponding to amino acids 88±103 of moth cytochrome c
(Schwartz et al., 1985); this same peptide with the lysine at position 1997), KMAC-126 (Liu et al., 1997); IEk/Hb-specific, KH-2 (not pre-
viously reported); IAd/OVA-specific, D0.11.10 (White et al., 1983),99 changed to alanine (MCC99A) (Reay et al., 1994); and a peptide
corresponding to amino acids 64±76 of mouse b-hemoglobin (Eva- 2B10.D2±22 (Seibel et al., 1997); IEk/MCC99A-specific, KC99A-4 (Liu
et al., 1997), KHAMA-3, KHAMA-48, KHAMA-50, KHAMA-56, andvold et al., 1992). The IAd molecule was produced bound to a peptide
corresponding to amino acids 328±338 of chicken ovalbumin (OVA) KHAMA-93 (not previously reported). The IAd/OVA-specific abTCRs
on D0.11.10 and 2B10.D2-22 were of identical sequence (Seibel et(Shimonkevitz et al., 1984). In addition to those previously reported,
new constructions were prepared by adding a sequence to the 39 al., 1997).
end of each MHC b chain encoding a peptide capable of being
biotinylated by the Escherichia coli enzyme BirA (Schatz, 1993). The Mice
Mice carrying either the AD10 or AND transgenic Va11/Vb3 abTCRfinal sequence was:
specific for IEk/MCC were a generous gift of Dr. Steven Hedrick,
University of California, San Diego (Kaye et al., 1992). They were
extensively backcrossed to H-2k-bearing B10.BR mice. Normal-Ek or Ad b2––––.,––––Linker––––
B10.BR mice were obtained from the Jackson Laboratory, Bar Har-ACGGTCGAGTGGAAAGCACAGTCCACTAGGGGT
bor, ME.
T V E W K A Q S T R G
Flowcytometric Analysis
The anti-Cb MAb H597 (Kubo et al., 1989) was used to estimate––––Linker–––––.,–Peptide Tag–––
surface abTCR on T cell hybridomas, and the anti-Vb3 antibodyGGAGCTAGCGGCGGTGGACTTGGAGGAATCTTT
KJ25 (Pharmingen, La Jolla, CA) was used to detect Vb3-bearing TG A S G G G L G G I F
cells. The anti-Ca MAb ADO-304 (Liu et al., 1998) was used to
capture soluble abTCR in biosensor flow cells. CD4 was detected
SphI with the MAb GK-1.5 (Dialynas et al., 1983). Cells labeled with fluo-
rescentantibodiesor soluble bio-MHC/peptide±PESA complexeswere––––––Peptide Tag––––––. ~
analyzed using an Epics XL flow cytometer (Coulter, Miami, FL).GAGGCAATGAAGATGGAGCTGCGGGACTGAGCATGCGGAT
E A M K M E L R D *
Soluble abTCR`
The genes for the variable portions of the a and b chains of the T
Site of Biotin Addition cell hybridoma KHAMA-93 were synthesized by PCR using cDNA
prepared from the hybridoma. The sequences of the CDR3 regions
of these gene segments were:Soluble MHC class II molecules were purified from culture super-
natants of infected High Five (InVitrogen) or SF9 insect cells by
immunoaffinity purification using monoclonal antibodies M5/114 (for
IAd) and 14-4-4 (for IEk). The final sample was stored in phosphate- KHAMA-93 Alpha
buffered saline with 5 mM NaN3, 0.7 mg/ml pepstatin, 1 mg/ml leu- TGTGCTGCCTCTCGGAATAGCAATAACAGA/
peptin, and 0.1 mM PMSF. C A A S R N S N N R /
––AV11S2–––.N,––––––––––––––––/
Biotinylated Soluble MHC/Peptide
Purified MHC class II molecules carrying the peptide tag werebiotin-
ylated (bio) using the enzyme BirA (Avidity, Denver, CO). Typically, AccIII
1 mg of protein at 1.8 mg/ml was incubated with 8±10 mg of BirA /GTGGTGAAGCCCAACATCCAGAATCCGGAA
at 258C for 16±20 hr in a buffer containing 10 mM Tris (pH 8), 50 / V V K P N I Q N P E
mM Bicine (pH 8.3), 10 mM ATP, 10 mM Mg acetate, and 40 uM /––––––––––.,––––––––––––Ca–––
biotin. Following the reaction, the unbound biotin was removed and
the buffer exchanged to PBS with 5 mM NaN3 using Centricon-30
KHAMA-93 Betaconcentrators (Amicon, Beverley, MA). The extent of biotinylation
was estimated by an ELISA of the soluble MHC class II before TGTGCCTGGAGTAGACACCTTAACCAAGAC/
and after removal of biotinylated protein with avidin±agarose beads C A W S R H L N Q D /
(Vector Labs, Burlingame, CA). Typically, z85% of the protein was ––BV14S1–––.,–––N–––.,––––––––/
biotinylated.
BglIIPreparation of Fluorescent Soluble Multivalent
MHC/Peptide Complexes /GGCACTCGGCTCCTCGTGTTAGAAGATCTG
Fluorescent multivalent MHC/peptide complexes were prepared by / G T R L L V L E D L
incubating purified bio-MHC/peptide with a covalent phycoer- /––––––––––––––––––––.,–––Cb2––
ythrin(PE)/streptavidin(AV) complex (BioSource International, Ca-
marillo, CA) at a calculated molar ratio of bio-MHC/peptide to SA
of 8:1. The mixture was then subjected to size exclusion FPLC The gene segments were cloned in-frame with the mouse Ca
or Cb genes in a baculovirus transfer vector and introduced bychromatography on Superdex-200 to separate the large molecular
weight bio-MHC/peptide±PESA complex from excess free MHC/ recombination into baculovirus as previously described (Kappler et
al., 1994; Seibel et al., 1997; Liu et al., 1998). Soluble abTCR waspeptide. The amount of uncomplexed bio-MHC/peptide recovered
and SDS-PAGE analysis of the complex indicated that the four bind- purified from the supernatants of infected High Five or SF9 insect
cells as previously described (Kappler et al., 1994).ing sites of SA for biotin were occupied with bio-MHC/peptide.
However, since the ratio of SA to PE in the commercial reagent was
2:1, some portion of the complex may have had a valence higher Surface Plasmon Resonance Studies
The BIAcore system (Biacore Inc., Piscataway, NJ) was used tothan four, and/or some free SA bound to bio-MHC/peptide may
have been present. evaluate the interaction of soluble MHC/peptide with soluble abTCR
as previously described (Seibel et al., 1997; Liu et al., 1998). In brief,
purified soluble TCR was immobilized in a flow cell of a biosensorT Cell Hybridomas
The T cell hybridomas used in this study were produced as pre- chip by capture with a high-affinity anti-Ca antibody. Various con-
centrations of the appropriate soluble MHC/peptide were injectedviously described (White et al., 1989). Most have been described in
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through the flow cell and the binding kinetics recorded. As controls, (1997). ab T cell receptor interactions with syngeneic and allogeneic
ligands: affinity measurements and crystallization. Proc. Natl. Acad.all preparations were injected through flow cells in which inappropri-
Sci. USA 94, 13838±13843.ate abTCR had been captured to correct for bulk fluid phase refrac-
tive index and any possible nonspecific binding. These data were Gay, D., Buus, S., Pasternak, J., Kappler, J., and Marrack, P. (1988).
subtracted from the experimental data. Standard BIAevalution soft- The T-cell accessory molecule CD4 recognizes a monomorphic de-
ware was used to analyze the kinetic data. terminant on isolated Ia. Proc. Natl. Acad. Sci. USA 85, 5629±5633.
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